BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15005287)

  • 1. Quality-of-life trials in lung cancer: past achievements and future challenges.
    Movsas B; Scott C
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):161-86. PubMed ID: 15005287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.
    Mannion E; Gilmartin JJ; Donnellan P; Keane M; Waldron D
    Support Care Cancer; 2014 May; 22(5):1417-28. PubMed ID: 24563068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving health-related quality of life in non-small-cell lung cancer with current treatment options.
    Cella DF; Patel JD
    Clin Lung Cancer; 2008 Jul; 9(4):206-12. PubMed ID: 18650167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in pretreatment quality of life in a prospective lung cancer trial.
    Siddiqui F; Kohl R; Swann S; Watkins-Bruner D; Movsas B
    J Support Oncol; 2008 Jan; 6(1):33-9. PubMed ID: 18257399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life in elderly patients with cancer.
    Di Maio M; Perrone F
    Health Qual Life Outcomes; 2003 Sep; 1():44. PubMed ID: 14525617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy.
    Dai YL; Yang CT; Chen KH; Tang ST
    J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial.
    Moinpour CM; Lyons B; Grevstad PK; Lovato LC; Crowley J; Czaplicki K; Buckner ZM; Ganz PA; Kelly K; Gandara DR
    Qual Life Res; 2002 Mar; 11(2):115-26. PubMed ID: 12018735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on qi deficiency syndrome distribution and quality of life in patients with advanced non-small cell lung cancer].
    Yuan L; Zhang PT; Yang ZY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):880-3. PubMed ID: 21866653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
    Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G
    J Thorac Oncol; 2007 Dec; 2(12):1091-7. PubMed ID: 18090580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective external convergence evaluation of two different quality-of-life instruments in lung resection patients.
    Pompili C; Brunelli A; Xiumé F; Refai M; Salati M; Socci L; Di Nunzio L; Sabbatini A
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):99-105. PubMed ID: 21159520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review.
    Poghosyan H; Sheldon LK; Leveille SG; Cooley ME
    Lung Cancer; 2013 Jul; 81(1):11-26. PubMed ID: 23562675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and related factors in patients with newly diagnosed advanced lung cancer: a longitudinal study.
    Liao YC; Shun SC; Liao WY; Yu CJ; Yang PC; Lai YH
    Oncol Nurs Forum; 2014 Mar; 41(2):E44-55. PubMed ID: 24578085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.
    Morita S; Kobayashi K; Eguchi K; Matsumoto T; Shibuya M; Yamaji Y; Sakamoto J; Ohashi Y
    Jpn J Clin Oncol; 2003 Sep; 33(9):470-6. PubMed ID: 14594941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non-Small Cell Lung Cancer and Bone Metastases: A Systematic Review.
    Hendriks LE; Hermans BC; van den Beuken-van Everdingen MH; Hochstenbag MM; Dingemans AM
    J Thorac Oncol; 2016 Feb; 11(2):155-73. PubMed ID: 26718881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' views of routine quality of life assessment following a diagnosis of early-stage non-small cell lung cancer.
    Pompili C; Boele F; Absolom K; Holch P; Clayton B; Smyllie E; Franks K; Velikova G
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):324-330. PubMed ID: 32830244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life as an independent prognostic factor in advanced non-small-cell lung cancer in general practice].
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Noma S; Iwaki M; Aso H; Sakamoto K; Shimizu J
    Nihon Kokyuki Gakkai Zasshi; 2006 May; 44(5):368-73. PubMed ID: 16780094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
    Dancey J; Shepherd FA; Gralla RJ; Kim YS
    Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.